+1,057.4%
MRNA vs VFC
-65.9%
+1,123.3%
-95.4%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for all.
| Period | Portfolio | VFC | Excess | Alpha |
|---|---|---|---|---|
| 1D | -3.6% | -2.6% | -1.1% | -3.0% |
| 7D | -20.0% | -3.5% | -16.5% | -19.3% |
| 30D | -1.3% | +19.6% | -20.8% | -5.1% |
| 3M | +240.0% | +36.5% | +203.5% | +217.6% |
| 6M | +339.0% | +22.3% | +316.7% | +316.5% |
| YTD | +630.0% | +13.4% | +616.6% | +602.9% |
| 1Y | +769.1% | +37.7% | +731.4% | +703.2% |
| 3Y | +181.2% | +25.3% | +155.9% | +153.7% |
| 5Y | -8.1% | -69.5% | +61.4% | -7.4% |
| All | +1,057.4% | -65.9% | +1,123.3% | +983.1% |
Cumulative growth
Daily Returns
Daily percentage return beside VFC.
Daily Out/Under-Performance
Portfolio return minus VFC return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × VFC return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over all: compounded portfolio wealth divided by compounded VFC wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
all analysis · Full analysis span regression · 6 months rolling